Mutations in the PTEN gene results in activation of the phosphatidyl inositol kinase/protein kinase B (PI3K)/Akt/mTOR) pathway and is universally associated with poor prognosis in glioma patients [55,56]. This evidence concerns the gene AKT1 and glioma.